{4-Oxo-5-[1-phenyl-meth-(Z)-ylidene]-2-thioxo-thiazolidin-3-yl}-acetic acid

ID: ALA66070

Cas Number: 1151944-57-8

PubChem CID: 1201131

Max Phase: Preclinical

Molecular Formula: C12H9NO3S2

Molecular Weight: 279.34

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)CN1C(=O)/C(=C/c2ccccc2)SC1=S

Standard InChI:  InChI=1S/C12H9NO3S2/c14-10(15)7-13-11(16)9(18-12(13)17)6-8-4-2-1-3-5-8/h1-6H,7H2,(H,14,15)/b9-6-

Standard InChI Key:  CMANXDDFFAZWJR-TWGQIWQCSA-N

Molfile:  

     RDKit          2D

 18 19  0  0  0  0  0  0  0  0999 V2000
   -2.9457    0.4459    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5588   -0.1062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3872   -0.9131    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6026   -1.1681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9895   -0.6161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1610    0.1909    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5480    0.7430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7633    0.4880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5084   -0.2966    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.3166   -0.2966    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5715    0.4880    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0959    0.9729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0959    1.7979    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3562    0.7430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9693    0.1909    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7539    0.4459    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7977   -0.6161    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.8015   -0.9640    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
  4  5  1  0
  2  3  1  0
  5  6  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12  8  1  0
  6  1  1  0
 10 18  2  0
  1  2  2  0
 12 13  2  0
  6  7  1  0
 11 14  1  0
  3  4  2  0
 14 15  1  0
  7  8  2  0
  8  9  1  0
 15 16  1  0
 15 17  2  0
M  END

Associated Targets(Human)

HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

ampC Beta-lactamase (730 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
blaTEM-1 Beta-lactamase TEM (67 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trypanosoma brucei (78846 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
dxr 1-deoxyxylulose-5-phosphate reductoisomerase (147 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
mdh Malate dehydrogenase (29 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
blm Metallo-beta-lactamase type 2 (65 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
bla Bacterial beta-lactamase TEM (177 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
blaUOE-1 Beta-lactamase CTX-M (117 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ampC Beta-lactamase AmpC (62480 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
bla Beta-lactamase OXA-10 (127 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 279.34Molecular Weight (Monoisotopic): 279.0024AlogP: 1.97#Rotatable Bonds: 3
Polar Surface Area: 57.61Molecular Species: ACIDHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 3.71CX Basic pKa: CX LogP: 2.44CX LogD: -0.86
Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.68Np Likeness Score: -1.65

References

1. Grant EB, Guiadeen D, Baum EZ, Foleno BD, Jin H, Montenegro DA, Nelson EA, Bush K, Hlasta DJ..  (2000)  The synthesis and SAR of rhodanines as novel class C beta-lactamase inhibitors.,  10  (19): [PMID:11012024] [10.1016/s0960-894x(00)00444-3]
2. Smith TK, Young BL, Denton H, Hughes DL, Wagner GK..  (2009)  First small molecular inhibitors of T. brucei dolicholphosphate mannose synthase (DPMS), a validated drug target in African sleeping sickness.,  19  (6): [PMID:19217283] [10.1016/j.bmcl.2009.01.083]
3. Zinglé C, Tritsch D, Grosdemange-Billiard C, Rohmer M..  (2014)  Catechol-rhodanine derivatives: Specific and promiscuous inhibitors of Escherichia coli deoxyxylulose phosphate reductoisomerase (DXR).,  22  (14): [PMID:24890653] [10.1016/j.bmc.2014.05.004]
4. Zhang D, Markoulides MS, Stepanovs D, Rydzik AM, El-Hussein A, Bon C, Kamps JJAG, Umland KD, Collins PM, Cahill ST, Wang DY, von Delft F, Brem J, McDonough MA, Schofield CJ..  (2018)  Structure activity relationship studies on rhodanines and derived enethiol inhibitors of metallo-β-lactamases.,  26  (11): [PMID:29655609] [10.1016/j.bmc.2018.02.043]
5. Xiang Y, Chen C, Wang WM, Xu LW, Yang KW, Oelschlaeger P, He Y..  (2018)  Rhodanine as a Potent Scaffold for the Development of Broad-Spectrum Metallo-β-lactamase Inhibitors.,  (4): [PMID:29670701] [10.1021/acsmedchemlett.7b00548]

Source